Stories of Innovation. Data to Back It Up. View the 2024 Impact Report >

Search

Seattle Genetics (SGEN), Unum Therapeutics Enter ACTR Therapies Development Agreement

XTuit Pharmaceuticals Closes $22 Million Series A Financing to Advance Novel Microenvironmental Modulators for Cancers and Fibrotic Disorders

Unum hits the gas on next-gen CAR-T tech after banking $65M round

NEA joins Polaris in backing XTuit's cancer/fibrosis pipeline with $22M A round

New Commitments in Support of the President’s Nation of Makers Initiative

Unum Therapeutics Announces $65 Million Series B Financing Round

Got a startup? Rent a bench

National Science Foundation Innovation Zone

Biotech billionaire Soon-Shiong steers immuno-oncology player Conkwest to $172.5M IPO

Aldatu Secures $1.5M NIH Grant to Commercialize HIV Drug-Resistance Test